SCHEMBL7658816

SCHEMBL7658816

CCn1nc(-c2c(C)cc(C)cc2C)c(C)c1CN1CCc2ccccc2C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ CD44 P16070 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ TAAR1 Q96RJ0 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ CXCR3 P49682 1/20 0.37
▸ TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7583200 0.92 HTT (0.42) HTTNPSR1SMN1; SMN2LMNACD44
SCHEMBL7583342 0.89 HTT (0.42) HTTNPSR1SMN1; SMN2LMNACD44
SCHEMBL7865778 0.80 SMN1; SMN2 (0.38) NPSR1SMN1; SMN2ALDH1A1
SCHEMBL7590419 0.79 CHRNA7 (0.45) LMNAATMKMT2AMEN1MAPT
SCHEMBL7580168 0.76 BCL2 (0.33) —
SCHEMBL7866024 0.75 OPRM1 (0.35) —
SCHEMBL7599235 0.73 HTT (0.43) HTTNPSR1SMN1; SMN2LMNACD44
SCHEMBL7580040 0.70 POLB (0.48) HTTLMNAPOLBKMT2AMEN1
SCHEMBL7583915 0.69 CRHR1 (0.33) —
SCHEMBL5512714 0.68 HTT (0.42) HTTNPSR1SMN1; SMN2LMNACD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6469041-B2 PSYCHOLOGICAL DISORDERS NEUROGEN CORPORATION 2002-10-22 — — US disclosed
US-6300360-B1 FOR THERAPY OF STRESS RELATED DISORDERS SUCH AS POST TRAUMATIC STRESS DISORDER (PTSD) AS WELL AS DEPRESSION, HEADACHE AND ANXIETY NEUROGEN CORPORATION 2001-10-09 — — US disclosed
US-6127399-A TREATING POST TRAUMATIC STRESS DISORDER AS WELL AS DEPRESSION, HEADACHE AND ANXIETY NEUROGEN CORPORATION (US) 2000-10-03 — — US disclosed
US-5973152-A Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands NEUROGEN CORPORATION 1999-10-26 — — US disclosed
Send feedback